Differences of use between paliperidone palmitate 3 month and paliperidone palmitate 1 month in real practice, with psychotic patients

INTRODUCTION: Paliperidone palmitate 1-month (PP1M) is a Long-acting injectable antipsychotic formulation, approved for the treatment of schizophrenia and schizoaffective disorder. Recently, paliperidone palmitate 3-months (PP3M) formulation was introduced, which maintains stability while offering a...

Descripción completa

Detalles Bibliográficos
Autores principales: Escobedo-Aedo, P., Merayo-Cano, J., Mata Iturralde, L., Muñoz Lorenzo, L., Ovejero, S., Sánchez Alonso, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567057/
http://dx.doi.org/10.1192/j.eurpsy.2022.1886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567057/
http://dx.doi.org/10.1192/j.eurpsy.2022.1886

Ejemplares similares